AU3014592A - Systemic control of parasites - Google Patents

Systemic control of parasites

Info

Publication number
AU3014592A
AU3014592A AU30145/92A AU3014592A AU3014592A AU 3014592 A AU3014592 A AU 3014592A AU 30145/92 A AU30145/92 A AU 30145/92A AU 3014592 A AU3014592 A AU 3014592A AU 3014592 A AU3014592 A AU 3014592A
Authority
AU
Australia
Prior art keywords
group
different
integer
hydrogen
halogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU30145/92A
Other versions
AU660205B2 (en
Inventor
Thomas A. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virbac Corp
Original Assignee
Virbac Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac Corp filed Critical Virbac Corp
Publication of AU3014592A publication Critical patent/AU3014592A/en
Assigned to VIRBAC, INC reassignment VIRBAC, INC Alteration of Name(s) of Applicant(s) under S113 Assignors: VIRBAC S.A.
Application granted granted Critical
Publication of AU660205B2 publication Critical patent/AU660205B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to a method for combating ectoparasites. More particularly, it relates to a treatment method in which the warm-blooded animal receives a dose of an effective amount, from the ovicidal viewpoint, of a heterocyclic compound containing nitrogen chosen from the group represented by the formula: <IMAGE> in which R1 is one of the following groups: <IMAGE> in which R7, R8, R9, R10, R11, R12, R13, R14, R15 , R16 and R17, which are identical or different, are each a hydrogen or halogen atom, a C1-4 alkoxy group, a C1-4 alkylthio group, a trifluoromethyl group or a nitro group; R18, R19, R20 and R21, which are identical or different, are each a hydrogen atom or a methyl group, k is an integer from 0 to 1 and l is an integer from 0 to 3; R2 and R3, which are identical or different, are each a hydrogen or halogen atom or a methyl group; R4 is a halogen atom or a methyl group; R5 and R6, which are identical or different, are each a hydrogen or halogen atom or a C1-4 haloalkyl or C1-4 haloalkoxy group; X, Y and Z, which are identical or different, are each an oxygen or sulphur atom or a methylene group, m is an integer from 0 to 4 and n is an integer from 0 to 2, which is transmitted to the ectoparasite via the blood of the animal. According to another aspect, a compound chosen from the group consisting of ivermectin, milbemycin, milbemycin oxime, moxidectin and avermectin and avermectin derivatives is also used.
AU30145/92A 1991-12-23 1992-12-15 Systemic control of parasites Ceased AU660205B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81243091A 1991-12-23 1991-12-23
US812430 1991-12-23

Publications (2)

Publication Number Publication Date
AU3014592A true AU3014592A (en) 1993-06-24
AU660205B2 AU660205B2 (en) 1995-06-15

Family

ID=25209544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30145/92A Ceased AU660205B2 (en) 1991-12-23 1992-12-15 Systemic control of parasites

Country Status (8)

Country Link
EP (1) EP0549441B1 (en)
JP (1) JP3170077B2 (en)
AT (1) ATE156357T1 (en)
AU (1) AU660205B2 (en)
DE (1) DE69221454T2 (en)
ES (1) ES2108099T3 (en)
NZ (1) NZ245548A (en)
ZA (1) ZA929950B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5632999A (en) * 1993-08-18 1997-05-27 Virbac, Inc. Sustained release pyriproxifen compositions for parasite control
TW328044B (en) * 1994-12-01 1998-03-11 Mitsui Toatsu Chemicals An insecticidal and acaricidal composition
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
EP1204413A2 (en) * 1999-07-23 2002-05-15 Bioparken AS Control of crustacean infestation of aquatic animals
AU5838000A (en) * 1999-07-23 2001-02-13 Bioparken As Novel juvenile hormone analogues and their use as antifouling agents
JP4288794B2 (en) * 1999-10-26 2009-07-01 住友化学株式会社 Insecticide and acaricide composition
JP4701538B2 (en) * 2001-05-21 2011-06-15 住友化学株式会社 Agricultural pest control composition
KR20140012013A (en) * 2010-07-30 2014-01-29 세바 상뜨 아니말르 Compositions for treating heartworm infestation
JP6033610B2 (en) * 2012-08-31 2016-11-30 日本ケーブル株式会社 Evacuation support device
US11147273B2 (en) * 2017-06-26 2021-10-19 Boehringer Ingelheim Animal Health USA Inc. Dual active parasiticidal granule compositions, methods and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US4031239A (en) 1975-02-13 1977-06-21 American Cyanamid Company Cyclopropanecarboxylates for systemic control of ectoparasites
US3962458A (en) 1975-02-13 1976-06-08 American Cyanamid Company Systemic control of ectoparasites with pyrethroids
US4006236A (en) 1975-08-04 1977-02-01 American Cyanamid Company Substituted octahydrophenanthridine pesticides
US4053631A (en) 1976-04-02 1977-10-11 American Cyanamid Company Systemic control of ectoparasites with α-cyano-m-phenoxybenzyl α1 -C4 alkyl-2-naphthaleneacetates
US4089975A (en) 1977-05-13 1978-05-16 The Dow Chemical Company Method of controlling manure-breeding insects
US4092421A (en) 1977-05-13 1978-05-30 The Dow Chemical Company Method of controlling manure-breeding insects
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4166107A (en) 1978-07-25 1979-08-28 The United States Of America As Represented By The Secretary Of Agriculture Sustained release bolus formulations containing insect growth regulators for control of livestock pests
JPS5632481A (en) 1979-08-23 1981-04-01 Sankyo Co Ltd Antibiotic b-41d, its preparation, and acaricide and anthelminthic agent and repellent containing the same as active constituent
FR2470104A1 (en) 1979-11-19 1981-05-29 Carbonisation Entr Ceram PULVERULENT COMPOSITION AND REFRACTORY PART OBTAINED FROM THE COMPOSITION
US4251223A (en) 1979-12-17 1981-02-17 Miles Laboratories, Inc. Sensitizers for peroxidative activity tests
US4323582A (en) 1980-07-21 1982-04-06 Siegel Norman H Method of treating animals and humans for internal and external parasites
JPS59108785A (en) 1982-11-25 1984-06-23 Sankyo Co Ltd 5-oxime derivative of milbemycins
JPS59199673A (en) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd Nitrogen-containing heterocyclic compound, its preparation and pesticide containing the same
US4694974A (en) 1985-06-14 1987-09-22 Michael Heck Escapement apparatus for an automatic screw feeding machine
ES8800986A1 (en) * 1985-07-27 1987-12-01 Pfizer Antiparasitic avermectin and milbemycin derivatives and process for their preparation.
NZ221262A (en) 1986-08-06 1990-08-28 Ciba Geigy Ag Preventing the reinfestation of dogs and cats by fleas by administering to the host a flea growth inhibiting substance orally, parenterally or by implant
US4751223A (en) 1986-10-14 1988-06-14 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic aminoalkyl tetracyclic benzodiazepines
DE3805235A1 (en) 1988-02-19 1989-08-31 Shell Int Research METHOD FOR PRODUCING 3,3-DIARYLACRYLIC ACID AMIDES
US4988824A (en) 1989-09-11 1991-01-29 Maulding Donald R Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds

Also Published As

Publication number Publication date
JP3170077B2 (en) 2001-05-28
EP0549441B1 (en) 1997-08-06
DE69221454T2 (en) 1997-12-11
JPH06211792A (en) 1994-08-02
ES2108099T3 (en) 1997-12-16
DE69221454D1 (en) 1997-09-11
EP0549441A1 (en) 1993-06-30
AU660205B2 (en) 1995-06-15
NZ245548A (en) 1996-04-26
ZA929950B (en) 1993-11-03
ATE156357T1 (en) 1997-08-15

Similar Documents

Publication Publication Date Title
DE69021472D1 (en) Pyrazole derivatives, processes for their preparation and pharmaceutical compositions containing them.
AU3014592A (en) Systemic control of parasites
FR07C0036I1 (en)
DK0829476T3 (en) 6-substituted acyclopyrimidine nucleoside derivatives and antivirals containing these derivatives as active ingredients
NO883146D0 (en) ANTI-INFLAMATORALLY ACTIVE ARYLED DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION.
AR002761A1 (en) A COMPOUND DERIVED FROM TRIAZOLE, ITS USE, A PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, A METHOD OF TREATMENT OR PREVENTION OF A FUNGAL INFECTION IN A HUMAN PATIENT THROUGH SUCH A COMPOUND OR COMPOSITION, AND INTERMEDIATE PROCEDURE AND COMPOUNDS TO PREPARE IT.
GR3021235T3 (en) Acetylenic derivatives and their use as plant-protective agents.
ATE107633T1 (en) PYRIMIDINONE DERIVATIVES.
HU9402502D0 (en) Novel arylindazoles and their use as herbicides
DE69313684D1 (en) 4-methyl-3-phenyl-2-oxo-3-pyrroline derivatives, process for their preparation and herbicides containing them
NO972943L (en) 4-Amino-2-ureido-pyrimidine-5-carboxylic acid amides, processes for their preparation, drugs containing them and their use
DE69620175T2 (en) HYDROXYLAMINE DERIVATIVES WITH ANTI-ISCHEMIC EFFECT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE372328T1 (en) ANGIOGENESIS-INHIBITING 5-SUBSTITUTED-1,2,4-THIADIAZOLYL DERIVATIVES
ES2055476T3 (en) THIOCARBAMOILACETONITRILE COMPOUNDS.
RO82994B1 (en) Antidote-containing herbicidal composition

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired